Literature DB >> 10205057

Functional arteries grown in vitro.

L E Niklason1, J Gao, W M Abbott, K K Hirschi, S Houser, R Marini, R Langer.   

Abstract

A tissue engineering approach was developed to produce arbitrary lengths of vascular graft material from smooth muscle and endothelial cells that were derived from a biopsy of vascular tissue. Bovine vessels cultured under pulsatile conditions had rupture strengths greater than 2000 millimeters of mercury, suture retention strengths of up to 90 grams, and collagen contents of up to 50 percent. Cultured vessels also showed contractile responses to pharmacological agents and contained smooth muscle cells that displayed markers of differentiation such as calponin and myosin heavy chains. Tissue-engineered arteries were implanted in miniature swine, with patency documented up to 24 days by digital angiography.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205057     DOI: 10.1126/science.284.5413.489

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  320 in total

Review 1.  Biologic alternatives to stents and grafts.

Authors:  N M Caplice
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

Review 2.  Tissue engineering of the vascular system: from capillaries to larger blood vessels.

Authors:  L Germain; M Rémy-Zolghadri; F Auger
Journal:  Med Biol Eng Comput       Date:  2000-03       Impact factor: 2.602

Review 3.  Physiology of angiogenesis.

Authors:  H Kurz
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

4.  Endothelial Cell Vascular Smooth Muscle Cell Co-Culture Assay For High Throughput Screening Assays For Discovery of Anti-Angiogenesis Agents and Other Therapeutic Molecules.

Authors:  George A Truskey
Journal:  Int J High Throughput Screen       Date:  2010-10-01

5.  Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration.

Authors:  Susan M Majka; Kathyjo A Jackson; Kirsten A Kienstra; Mark W Majesky; Margaret A Goodell; Karen K Hirschi
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 6.  Bone-marrow stem cells as a source for cell therapy.

Authors:  Ray C-J Chiu
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 7.  Genetic modification of xenografts.

Authors:  J L Platt
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

8.  Dynamic culture conditions to generate silk-based tissue-engineered vascular grafts.

Authors:  Xiaohui Zhang; Xiuli Wang; Vinny Keshav; Xiaoqin Wang; Jacqueline T Johanas; Gary G Leisk; David L Kaplan
Journal:  Biomaterials       Date:  2009-02-20       Impact factor: 12.479

9.  Assembly of Tissue-Engineered Blood Vessels with Spatially Controlled Heterogeneities.

Authors:  Hannah A Strobel; Tracy A Hookway; Marco Piola; Gianfranco Beniamino Fiore; Monica Soncini; Eben Alsberg; Marsha W Rolle
Journal:  Tissue Eng Part A       Date:  2018-08-20       Impact factor: 3.845

10.  Computational model of the in vivo development of a tissue engineered vein from an implanted polymeric construct.

Authors:  K S Miller; Y U Lee; Y Naito; C K Breuer; J D Humphrey
Journal:  J Biomech       Date:  2013-10-21       Impact factor: 2.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.